Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural MRI Volumetry Index for Differentiation of Progressive Supranuclear Palsy From Parkinson's Disease and Multiple System Atrophy by Automatic Segmentation: A Comparison With Magnetic Resonance Parkinsonism Index.

Journal of magnetic resonance imaging : JMRI·2026
Same author

Competitive-adsorption-resistant interfacial regulation by 2-mercaptopyridine enables selective copper microvia superfilling.

Journal of colloid and interface science·2026
Same author

A Case Report of Acute Intermittent Porphyria Accompanied by Severe Peripheral Neuropathy.

Diagnostics (Basel, Switzerland)·2026
Same author

Manual therapy combined with core muscle training for chronic non-specific low back pain in sedentary individuals: a study protocol for a single-center randomized controlled trial.

Frontiers in medicine·2026
Same author

Nrf2 promotes NLRP3 inflammasome assembly and activation by Klf9-TXNIP axis.

Cell death discovery·2026
Same author

Premature Aortic Stiffness in Relation to Cerebral Small Vessel Disease, Cognitive Decline, Major Cardiovascular Events and Mortality in Dialysis.

American journal of nephrology·2026

Related Experiment Video

Updated: Mar 23, 2026

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
09:20

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

4.4K

A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.

Caifeng Yan1,2, Jinfeng Chen3, Min Li2

  • 1Department of Endocrinology, Clinical Medical College of Yangzhou University, Yangzhou, China.

Diabetologia
|March 23, 2016
PubMed
Summary
This summary is machine-generated.

Reduced microRNA-9 (miR-9) expression in obese mice is linked to increased gluconeogenesis. Restoring miR-9 improves insulin sensitivity and inhibits hepatic glucose production, highlighting its role in metabolic regulation.

Keywords:
DNA methylationFOXO1Insulin resistanceMicroRNA-9

More Related Videos

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

17.2K
Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
11:03

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes

Published on: September 9, 2021

4.6K

Related Experiment Videos

Last Updated: Mar 23, 2026

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
09:20

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

4.4K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

17.2K
Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
11:03

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes

Published on: September 9, 2021

4.6K

Area of Science:

  • Metabolic regulation
  • Molecular biology
  • Diabetes research

Background:

  • MicroRNA-9 (miR-9) is known to regulate pancreatic beta cell function.
  • The specific role of miR-9 in hepatic gluconeogenesis remains largely uncharacterized.
  • Understanding miR-9's function in glucose metabolism is crucial for metabolic disease research.

Purpose of the Study:

  • To investigate the role of microRNA-9 (miR-9) in hepatic glucose production (HGP).
  • To elucidate the regulatory mechanisms of miR-9 in the context of obesity and gluconeogenesis.
  • To determine the impact of miR-9 modulation on glucose homeostasis and insulin sensitivity.

Main Methods:

  • Assessed miR-9 expression and promoter methylation in livers of diet-induced obese and genetic obese mouse models.
  • Utilized methylation-specific PCR, ChIP, and quantitative real-time PCR to analyze miR-9 promoter regulation by DNA methyltransferases (DNMTs).
  • Evaluated HGP in vitro and in vivo, alongside glucose tolerance, insulin tolerance, and pyruvate tolerance tests.

Main Results:

  • Obese mice exhibited reduced miR-9 expression and increased miR-9-3 promoter hypermethylation.
  • DNA methyltransferase 1 (DNMT1) binding to the miR-9-3 promoter was elevated in obese hepatocytes, suppressing miR-9 expression.
  • Overexpression of hepatic miR-9 improved insulin sensitivity and inhibited HGP in obese mice, while miR-9 deletion increased blood glucose levels.
  • Silencing forkhead box O1 (FOXO1) reversed the effects of miR-9 deletion on gluconeogenesis.

Conclusions:

  • Decreased miR-9 expression contributes to dysregulated gluconeogenesis in obese mice.
  • miR-9 plays a critical role in regulating hepatic glucose production and insulin sensitivity.
  • Targeting miR-9 may represent a therapeutic strategy for managing metabolic disorders associated with hyperglycemia.